| Molecular Subtypes and Local-Regional Control of Breast Cancer |
52 |
| Systemic Therapy for Colon Cancer |
16 |
| Lymph Node Metastasis in Colorectal Cancer |
15 |
| Triple-Negative Breast Cancer Who Should Receive Neoadjuvant Chemotherapy? |
11 |
| Colon Cancer Inflammation-Associated Cancer |
10 |
| Clinical Trials and Progress in Metastatic Colon Cancer |
10 |
| Evolving Treatment Strategies and Outcomes in Advanced Gastric Cancer with Peritoneal Metastasis |
8 |
| Virtual and Augmented Reality in Oncologic Liver Surgery |
7 |
| Minimally Invasive Surgery for Primary and Metastatic Adrenal Malignancy |
7 |
| Health-Related Quality of Life The Impact on Morbidity and Mortality |
7 |
| Regionalization and Its Alternatives |
7 |
| Surgical Intervention for Lymphedema |
6 |
| Peritoneal Metastases, a Frontier for Progress |
6 |
| Learning Curve, Training Program, and Monitorization of Surgical Performance of Peritoneal Surface Malignancies Centers |
6 |
| Pharmacokinetics and Tissue Transport of Intraperitoneal Chemotherapy |
6 |
| Minimally Invasive Gastric Cancer Surgery |
6 |
| Colon Cancer: What We Eat |
6 |
| Minimally Invasive Surgery for Gallbladder Cancer |
5 |
| Minimally Invasive Surgical Approaches to Colon Cancer |
5 |
| The Economics of Colon Cancer |
5 |
| Fluorescence Imaging for Minimally Invasive Cancer Surgery |
5 |
| Peritoneal Metastases from Colorectal Cancer Treatment Principles and Perspectives |
5 |
| Anatomy and Breast Cancer Staging: Is It Still Relevant? |
5 |
| The Current Landscape of Immune Checkpoint Inhibition for Solid Malignancies |
5 |
| Intraoperative Margin Assessment in Breast Cancer Management |
5 |
| Imaging for Peritoneal Metastases |
4 |
| Lobular Breast Cancer Different Disease, Different Algorithms? |
4 |
| Current Immunotherapy Practices in Melanoma |
4 |
| Immunotherapy in Ovarian Cancer |
4 |
| Peritoneal Metastases from Appendiceal Cancer |
4 |
| Minimally Invasive Colon Cancer Surgery |
4 |
| Minimally Invasive Surgery for Locally Advanced Rectal Cancer |
4 |
| Surgical Treatment of Metastatic Colorectal Cancer |
4 |
| Minimally Invasive Primary Liver Cancer Surgery |
3 |
| Minimally Invasive Techniques in Urology |
3 |
| History of Minimally Invasive Surgical Oncology |
3 |
| Population Screening for Hereditary Colorectal Cancer |
3 |
| Transluminal Cancer Surgery |
3 |
| Gallbladder Cancer Managing the Incidental Diagnosis |
3 |
| Intrahepatic Cholangiocarcinoma |
3 |
| When Does Atypical Ductal Hyperplasia Require Surgical Excision? |
3 |
| Palliative Management of Advanced Peritoneal Carcinomatosis |
3 |
| Breast Cancer Disparities How Can We Leverage Genomics to Improve Outcomes? |
3 |
| Implications of the Affordable Care Act on Surgery and Cancer Care |
2 |
| Regional Chemotherapy for Biliary Tract Tumors and Hepatocellular Carcinoma |
2 |
| Nonsurgical Approaches to Treat Biliary Tract and Liver Tumors |
2 |
| Surgical Considerations of Hilar Cholangiocarcinoma |
2 |
| Approaches and Outcomes to Distal Cholangiocarcinoma |
2 |
| Immunotherapy Toxicities |
2 |
| Vaccine Therapies for Breast Cancer |
2 |
